Aortica

Aortica Corporation was founded to design, manufacture, and market tools for treatment of patients

Aortica Corporation was founded to design, manufacture, and market tools for treatment of patients with AAA disease who have aortic anatomy that limits their treatment options. While EVAR has become the gold standard for treatment of AAA disease, between 30-40% of patients are not candidates for EVAR because their aortic anatomy is structured in a manner that does not allow an endograft to be anchored properly. The only option for these patients is major open surgery. Aortica has developed a “patient-specific” solution to this problem by combining a patient’s CT scans with its proprietary software and 3-D printing to customize a standard endograft to fit precisely and anchor securely within each patient.